Biomed Israel 2022 PROGRAM
TUESDAY, MAY 10
| 09:00 - 09:15 | Welcome by Conference Chairpersons: |
| Ruti Alon, Founder and CEO, Medstrada | |
| Ora Dar, PhD, Senior Expert, Medical Sciences and Health Innovation | |
| Nissim Darvish, MD, PhD, Managing General Partner, MeOHR Ventures | |
| 09:15 - 09:30 | Coffee Break |
| HALL A | |
| 09:30 - 14:00 | CELL, GENE AND NUCLEIC ACIDS THERAPIES - THE NEXT FRONTIER IN HUMAN HEALTH |
| 11:00 - 11:30 | Coffee Break |
| Chairpersons: Erez Chimovits, Orbimed Partner, Private Equity, Rami Skaliter, PhD, CEO, Cell Cure Neurosciences | |
| 09:30 - 09:40 | Opening Remarks: Erez Chimovits, Orbimed Partner, Private Equity |
| 09:40 - 10:00 | Sumant Ramachandra, MD, PhD, President and CEO, ImmPACT Bio, "Autologous CAR-T based therapies," "ZOOM" |
| 10:00 - 10:20 | Chen Schor, President and CEO, Adicet Bio, "Allogeneic CAR-T based therapies" |
| 10:20-10:35 | Noam Pilpel, PhD, CTO, Gilboa Therapeutics |
| 10:35 - 10:55 | Zhen Li, PhD, President and CEO, ADARx Pharmaceuticals, "Oligonucleotide therapeutics" |
| 11:30 - 11:45 | Gili Hart, CEO, Splisense |
| 11:45 - 12:05 | Adel Nada, MD, Co-founder and CEO, GentiBio, "T-regs for curing autoimmunity" |
| 12:05 - 12:25 | David Baram, PhD, President and CEO, Emendo Biotherapeutics, "Gene editing based therapies" |
| 12:25 - 12:45 | Michal Golan Mashiach, PhD, Founder and CEO, EdiTy Therapeutics |
| 12:45 - 13:00 | Rami Skaliter, PhD, CEO, Cell Cure Neurosciences, "Embrionic stem cells therapies" |
| 13:00 - 13:15 | Yona Geffen, PhD, VP, R&D, Gamida Cell |
| 13:15 - 13:30 | Noam Diamant, PhD, Co-founder and CEO, Noga Therapeutics |
| 13:30 - 13:45 | Adi Elkeles, PhD, Founder and CEO, Trobix Bio |
| 13:45 - 14:00 | Prof. Dror Mevorach, MD, CSO, Enlivex Therapeutics, "Allocetra-OTS: High synergistic effectiveness against solid tumor with immune check point inhibitors or CAR T." |
| 14:00 - 15:00 | Lunch Break |
| HALL B | |
| 09:30 - 14:00 | MEDICAL DEVICE - BREAKTHROUGH TECHNOLOGIES |
| 11:00 - 11:30 | Coffee Break |
| Chairperson: Eyal Lifschitz, Co-founder and General Managing Partner, Peregrine Ventures |
|
| 09:30 - 09:45 | David Rigler, VP Clinical Research and Regulatory Affairs, Nano Retina |
| 09:45 - 10:00 | Ronen Eckhouse, Co-founder and CEO, Rapid Medical |
| 10:00 - 10:15 | Amir Danino, Founder and CEO, Innoventric |
| 10:15 - 10:30 | Shlomit Chappel-Ram, PhD, VP, R&D, Digma Medical |
| 10:30 - 10:45 | Yotam Drechsler, CEO and Co-founder, BrainQ Technologies |
| 10:45 - 11:05 | Daniel Goldstein, PhD, Advocate and Patent Attorney, Sanford T. Colb & Co., "Ecosystems and homeostasis: A law and technology look at the field of medical devices" |
| 11:30 - 11:45 | Ronen Segal, CTO, Alpha Tau Medical |
| 11:45 - 12:00 | Avner Geva, Founder and CEO, Vensica Therapeutics |
| 12:00 - 12:15 | Idan Geva, CEO, |
| 12:15 - 12:35 | Joseph (Joe) Smith, MD, PhD, CSO, Becton Dickinson, "BD - Innovation at Scale" |
| 12:35 - 12:50 | Benny Dilmoney, CEO, Magneto Thrombectomy Solutions |
| 12:50 - 13:05 | Gilad Marom, CEO, Restore Medical |
| 13:05 - 13:20 | Dvir Cohen, CEO and President, Memic Innovative Surgery |
| 13:20 - 13:30 | Closing Remarks: Eyal Lifschitz, Co-founder and General Managing Partner, Peregrine Ventures |
| 13:30 - 13:50 | Sandra Morgan, Board Director and Advisor, Healthcare, Pharmaceutical, and Technology, "MedTech 2032: The Future" |
| 14:00 - 15:00 | Lunch Break |
| HALL C | |
| 09:30-14:00 | BIO FOOD - NEW ERA OF FOOD TECHNOLOGIES; ITS IMPACT ON NUTRITION AND HEALTH |
| 11:00 - 11:30 | Coffee Break |
| Chairperson: Tammy Meiron, PhD, CTO, Fresh Start FoodTech Incubator | |
| 09:30 - 09:55 | Valerio Nanninni, General Manager, Novozymes Advanced Proteins Solutions, "The food industry perspective and the adaptation of bio-tech technologies" |
| 09:55 - 10:20 | Matthew Robin, CEO, Mifloma Group-at Migros Industries, "The perspective of a leading FoodTech company, entering the Bio Food arena" |
| 10:20 - 10:45 | Prof. Yaakov Nahmais, PhD, Founder and President, Future Meat Technologies, "The evolution of a Bio Food Company in the eye of an academic researcher" |
| 10:45 - 11:00 | Ilan Samish, Phd, Founder and CEO, Amai Proteins |
| 11:30 - 11:55 | Prof. Eldad Tzahor, PhD, Co-founder and scientific advisor, Profuse Tech, "Bioconversion - the Case Study of Profuse" |
| 11:55 - 12:20 | Miriam Guggenheim, Co-chair, Covington’s Israel International Initiative, "Regulatory barriers and challenges in adaptation of bio-tech platforms into foods" |
| 12:20 - 12:35 | Tal Lutzky, Co-founder and CEO, Pigmentum |
| 12:35 - 12:50 | Neta Lavon, PhD, CTO, Aleph Farm |
| 12:50 - 13:05 | Orna Harel, PhD, Co-founder and CEO, Sea 2 Cell |
| 13:05 - 13:20 | Tsipi Shoham, PhD, Co-founder and CEO, GreenOnyx |
| 13:20 - 13:35 | Iftach Nachman, PhD, Co-founder and Scientific Advisor, Forsea |
| 13:35 - 13:50 | Fabian Trumper, Co-founder and CEO, Bountica |
| 13:50 - 14:05 | Prof. Nurit Argov-Argaman, PhD, CTO, Wilk |
| 14:00 - 15:00 | Lunch Break |
| PLENARY SESSION | |
| 15:15 - 15:45 | Mikael Dolsten, MD, PhD, Chief Scientific Officer and President, "ZOOM" Fireside Chat with: Gil Bar-Nahum, PhD, Managing Director, Jefferies International, UK |
| 15:45 - 16:15 | Robert Cohen, MS, President, Digital, Robotics, and Enabling Technology, Stryker, "Orthopedic industry and clinical insights - AI and predictive analytics," "ZOOM" |
| 16:15 - 16:45 | Gil Bar-Nahum, PhD, Managing Director, Jefferies International, UK, "The State of Life Sciences Industry, Today and Tomorrow" |
| 16:45 - 17:15 | Sandra Morgan, Board Director and Advisor, Healthcare, Pharmaceutical, and Technology, "Trials and Tribulations on the Riad to Marketing and Selling your Products to the USA Healthcare System" |
| 17:30 - 20:00 | Gala Event |
WEDNESDAY, MAY 11
| HALL A | |
| 09:30 - 11:30 | ACADEMIA - WHERE IS IT TAKING US? SCIENCE AND TECHNOLOGY - PREDICTION AND ANTICIPATION |
| 11:00 - 11:30 | Coffee Break |
| Chairperson: Keren Primor Cohen, CEO, Ramot Tel Aviv University | |
| 09:30 - 09:35 | Opening Remarks: Keren Primor Cohen, CEO, Ramot Tel Aviv University |
| 09:35 - 09:42 | Tamar Harel Adar, PhD, VP R&D, Matricelf |
| 09:42 - 09:49 | Yan Ostrovski, PhD, Co-founder and CEO, Neshima Medical |
| 09:49 - 09:55 | Pini Tsukerman, PhD, Co-founder and CEO, > NectinTX Therapeutics |
| 09:55 - 10:02 | Prof. Ehud Gazit, PhD, Professor, Blavatnik Center for Drug Discovery |
| 10:02 - 10:09 | Ophir Herbst, CEO, Sequentify |
| 10:09 - 10:14 | Prof. Ronit Satchi-Fainaro, PhD, Head and Director, Cancer Biology Research Center, Tel Aviv University |
| 10:14 - 10:21 | David Gabay, Co-founder, Chairman and CEO, Madrigal Mental Care |
| 10:21 - 11:35 | Panel "Building a commercialization marketplace - no more "academic ivory towers"" |
| 10:21 - 10:36 | Moderator: Keren Primor Cohen, CEO, Ramot Tel Aviv University |
| 10:36 - 11:35 | Yuval Cabilly, PhD, Co-founder and Managing Partner, Israel Biotech Fund |
| 10:36 - 11:35 | Joel Bar-El, Founder and Executive Chairman, Unicorn Trax |
| 10:36 - 11:35 | Prof. Jacob (Koby) Rubinstein, PhD, VP, R&D and Chairman, T3 - Technion Technology |
| 10:36 - 11:35 | Aviv Zeevi, PhD, VP, Head of Division, Israel Innovation Authority |
| 10:36 - 11:35 | Lior Shahory, General Partner, Peregrine Ventures |
| HALL A | |
| 12:00-14:00 | BIO CONVERGENCE - ENGINEERING AND BIOTECHNOLOGY COMBINED, EXPANDING TO OTHER VERTICALS |
| Chairperson: Efi Cohen Arazi, CEO, TanoMed | |
| 12:00 - 12:05 | Opening Remarks: Efi Cohen Arazi, CEO, TanoMed |
| 12:05 - 12:10 | Dror Bin, CEO, Israel Innovation Authority |
| 12:10 - 12:22 | Daniel N. Weiss, MD, Medical Director, Enopace Biomedical |
| 12:22 - 12:34 | Aryeh Batt, CEO and Co-founder, Precise Bio |
| 12:34 - 12:46 | Ofri Vaisman, COO and General Manager, BlueWind Medical |
| 12:46 - 12:58 | Iris Alroy, PhD, CSO and CO-founder, Anima Biotech |
| 12:58 - 13:10 | Alon Meir, PhD, CSO, Seevix Material Sciences |
| 13:10 - 13:22 | Yuval Mandelbaum, CEO, Discure Technologies |
| 13:22 - 14:00 | Panel "Bio Convergence talent: the multidisciplinary opportunity and challenge” |
| Moderator: Daphna Murvitz, Ceo and Co-founder, 8400-The Health Network | |
| Tzvika Hartman, SVP Computational, Biolojic Design | |
| Aryeh Batt, CEO and Co-founder, Precise Bio | |
| Prof. Ronit Satchi-Fainaro, PhD, Head and Director, Cancer Biology Research Center, Tel Aviv University, | |
| Merav Bassan, PhD, CDO, BiomX | |
| 14:00-15:00 | Lunch Break |
| HALL B | |
| 09:30 - 14:00 | AI AND MACHINE LEARNING - TRANSFORMING TREATMENT, DRUG DISCOVERY AND DEVELOPMENT |
| 11:00 - 11:30 | Coffee Break |
| Chairperson: Yair Benita, PhD, CTO, AION Labs | |
| 09:30 - 09:45 | Shai Shen-Orr, PhD, Co-founder and Chief Scientist, CytoReason |
| 09:45 - 10:00 | Micah Pearlman, CEO, Biolojic |
| 10:00 - 10:15 | Ranit Aharonov, PhD, CTO, Pangea Biomed |
| 10:15 - 10:30 | Anat Binur, PhD, Co-founder and CEO, UKKO |
| 10:30 - 10:45 | Noam Solomon, PhD, CEO, Immunai |
| 10:45 - 11:00 | Isaac Bentwich, MD, Founder and CEO, Quris Technologies |
| 11:30 - 11:45 | Nadav Askari, PhD, CTO, Genetika+ |
| 11:45 - 12:15 | James Weatherall, PhD, VP, Data Science and Artificial Intelligence, R&D, AztrtaZeneca, "Pushing the boundaries of science through Data Science and Artificial Intelligence," "ZOOM" |
| 12:15 - 12:45 | Eran Harary, MD, Global Head, Specialty R&D, Teva Pharmaceuticals, "The innovative productivity crisis in the pharmaceutical R&D - Challenges and Potential AI and ML Solutions" |
| 12:45 - 13:15 | Jason Johnson, PhD, Chief Data and Analytics Officer, SVP, Dana Farber Cancer Institute, "It's about the Data: strategies for enabling and productionizing Al and Machine learning," "ZOOM" |
| 13:15 - 13:45 | David Berry, MD, PhD, Founder, CEO and General Partner at Flagship Pioneering, Valo Health, "Accelerating drug discovery and development," "ZOOM" |
| 13:45 - 14:00 | Yair Benita, PhD, CTO, AION Labs |
| 14:00 - 15:00 | Lunch Break |
| HALL C | |
| 09:30 - 14:00 | CURRENT AND FUTURE ROLE OF ROBOTICS IN THE MEDICAL FIELD |
| 11:00 - 11:30 | Coffee Break |
| Chairperson: Dvir Cohen, CEO and President, Memic Innovative Surgery | |
| 09:30 - 09:35 | Opening Remarks: Dvir Cohen, CEO and President, Memic Innovative Surgery |
| 09:35 - 10:00 | Prof. Alexandre Mottrie, PhD, MD, CEO, Orsi Academy, "Past, present and future of surgical robotics, "ZOOM" |
| 10:00 - 10:25 | Gus Castello, Cognos-Lux Consulting LLC, "Building operational excellence in surgical robotics" |
| 10:25 - 10:50 | Michael Kasser, PhD, Director of Regulatory Sciences, Hogan Lovells, |
| 10:50 - 11:05 | Seong Ryong Kang, PhD, CEO, Korea-Israel industrial R&D foundation (KORIL), "ZOOM" with Hadar Zax, Program Manager at Israel Asia-Pacific Division, "Israel and S. Korea-the lighthouse program" |
| 11:30 - 11:45 | Michael Conditt, PhD, SVP, Strategic Marketing and Clinical Development, Memic Innovative Surgery |
| 11:45 - 12:00 | Tami Frenkel, PhD, Co-founder and CEO, Human Xtensions |
| 12:00 - 12:15 | Chen Levin, CEO, Xact Robotics |
| 12:15 - 12:30 | Noam Hassidov, CEO, Tamar Robotics |
| 12:30 - 12:45 | Gaddi Menahem, VP, Head of Intuitive Israel, Intuitive |
| 12:45 - 13:00 | Yosi Weitzman, Founder, COO/CTO, GM Israeli Site, Carevature Medical |
| 13:00 - 13:15 | Eyal Morag, MD, CMO, Microbot Medical |
| 13:15 - 13:30 | Lawrence Obstfeld, CEO, Image Navigation |
| 13:30 - 13:55 | Maurice R. Ferre, MD, Former co-founder and CEO, Mako Surgical, "Building a robotic company: lessons learned," "ZOOM" |
| 13:55 - 14:00 | Closing Remarks: Dvir Cohen, CEO and President, Memic Innovative Surgery |
| 14:00 - 15:00 | Lunch Break |
| PLENARY SESSION | |
| 15:15 - 15:35 | Dror Bin, CEO, Israel Innovation Authority |
| 15:35 - 16:05 | Janneke Van Der Kamp, Head Region Europe, Novartis, "Bending the Curve of Life:how partnerships can redefine cardiovascular disease care" |
| 16:05 - 16:45 | Robert S. Langer, DSc, Institute Professor, MIT Department of Chemical Engineering, "ZOOM" Fireside Chat with: Amy W. Schulman, Managing Partner, Polaris Partners, "ZOOM" |
| 16:45 - 17:15 | John D. Halamka, MD, MS, President, Mayo Clinic Platform, "ZOOM" |
THURSDAY, MAY 12
| HALL A | |
| 09:30-14:00 | TRANSFORMATIVE PRECISION CANCER DIAGNOSTICS AND THERAPIES |
| 11:00 - 11:30 | Coffee Break |
| Chairperson: Ofer Sharon, MD, CEO, OncoHost | |
| 09:30 - 09:35 | Opening Remarks: Ofer Sharon, MD, CEO, OncoHost, "Precision medicine challenges and opportunities" |
| 09:35 - 09:45 | Prof. Dror Harats, MD, CEO, VBL Therapeutics, "New Treatment strategies for Solid Tumors: major Leaps, but still work to be done" |
| 09:45 - 10:00 | Prof. Dror Harats, MD, CEO, VBL Therapeutics |
| 10:00 - 10:15 | Roni Mamluk, PhD, Founder and CEO, Ayala Pharma |
| 10:15 - 10:30 | Isaac Israel, CEO, Purple Biotech |
| 10:30 - 10:45 | Ilana Mandel, PhD, VP, R&D, Biond Biologics |
| 10:45 - 11:00 | Eran Ophir, PhD, VP Research and Drug Discovery, Compugen |
| 11:30 - 12:00 | Reddy Prasanth, MD, SVP, Global Enterprise Oncology Head, Covance/Labcorp Drug Development |
| 12:00 - 12:15 | Ronen Eavri, PhD, Co-founder and CEO, Barcode Nanotech Next Generation Therapeutics |
| 12:15 - 12:30 | Ofer Sharon, MD, CEO, OncoHost |
| 12:30 - 12:45 | Avi Veidman, Co-founder and CEO, Nucleai |
| 12:45 - 13:00 | Vered Bar, PhD, VP, R&D, Curesponse |
| 13:00 - 13:15 | Inbal Zafir-Lavie, PhD, CEO and Co-founder, Gina Life |
| 13:15 - 13:30 | Roi Feingersch, PhD, CEO and Founder, FORESEE GENOMICS |
| 13:30 - 13:45 | Assaf Halevy, Founder and CEO, 2bPrecise, Genomics and Precision Medicine |
| 14:00 - 15:00 | Lunch Break |
| HALL B | |
| 09:30-14:00 | DIGITAL RECONSTRUCTION OF HEALTHCARE |
| 11:00 - 11:30 | Coffee Break |
| Chairperson: Anat Naschitz, Founder and CEO, 9xchange; Co-founder, OrbiMed Israel | |
| 09:30 - 09:35 | Opening Remarks: Anat Naschitz, Founder and CEO, 9xchange; Co-founder, OrbiMed Israel |
| 09:35 - 09:55 | Guy Spigelman, EMEA Lead Healthcare and Life Sciences Startups, Amazon Web Services (AWS), "How Big Tech and High Performance Computing will Impact Healthcare and Life Sciences" |
| 09:55 - 10:15 | Elliot Menschik, MD, PhD, CDO, Resilience, "Software-defined biomanufacturing of therapeutics" |
| 10:15 - 10:30 | Avinatan Hassidim, Head of Google Israel research group, Google, "Reimagining the medical record" |
| 10:30 - 10:45 | Prof. Sam Shah, PhD, Chief Medical Strategy Officer, Numan, "Digital first: building a full stack health provider inside and outside the NHS" |
| 10:45 - 11:00 | Dedi Gilad, CEO and Co-founder, TytoCare, "The state of virtual care industry in the post-COVID era," Fireside chat with: Anat Naschitz, Founder and CEO, 9xchange; Co-founder, OrbiMed Israel |
| 11:30 - 11:45 | Amnon Bar Lev, Co-founder and CEO, Alike.Health |
| 11:45 - 12:00 | Kira Radinsky, PhD, Founder, CEO and CTO, Diagnostic Robotics |
| 12:00 - 12:15 | Anat Naschitz, Founder and CEO, 9xchange,; Co-founder, OrbiMed Israel, "9xchange, molecule marketplace" |
| 12:15 - 12:30 | Amir Trabelsi, Co-founder and CEO, Genoox |
| 12:30 - 12:45 | Orr Inbar, Co-founder and CEO, QuantHealth |
| 12:45 - 13:00 | Israel (Srulik) Dvorsky, Co-founder and CEO, TailorMed |
| 13:00 - 13:15 | Itai Gueta, MD, Institue of Clinical Pharmacology, Sheba Tel Ha Shomer Medical Center, "MDCIone - customer perspective" |
| 13:15 - 13:30 | Eliran Malki, Co-founder and CEO, Belong.Life |
| 13:30 - 13:45 | Chris Guiffre, CFO and COO, Pear Therapeutics "ZOOM" |
| 14:00 - 15:00 | Lunch Break |
| HALL C | |
| 09:30 - 14:00 | INFECTIOUS DISEASES - BREAKING BARRIERS IN VACCINE DEVELOPMENT, THERAPY AND DIAGNOSIS MODALITIES |
| 11:00 - 11:30 | Coffee Break |
| Chairperson: Prof. Dror Mevorach, MD, Head of Internal Medicine, Hadassah Hospital | |
| 09:35 - 09:55 | Prof. Dror Mevorach, MD, Head of Internal Medicine, Hadassah Hospital, "Covid19, where are we going?" |
| 10:00 - 10:20 | BARRY GREENE, CEO, Sage Therapeutics, USA, "COVID exacerbating mental health issues," |
| 10:20 - 10:40 | Prof. Jacob Strahilevitz, MD, Head of the department of Infectious Diseases and Clinical Microbiology, Hadassah Medical Center, "Antimicrobial stewardship: A societal need to combat resistance" |
| 10:40 - 11:00 | Prof. Ronen Ben Ami, MD, Head of the Infectious Diseases Unit, Tel Aviv Medical Center, "Emerging Fungal Threats in 2022" |
| 11:30 - 11:45 | Nadav Ben-Dov, PhD, CEO and Co-founder, phenofAST |
| 11:45 - 12:00 | Eynat Finkelshtein, PhD, CSO, Code Pharma |
| 12:00 - 12:15 | Moshik Cohen-Kutner, PhD, CEO, Omnix Medical |
| 12:15 - 12:30 | Jonathan Solomon, CEO and Board Member, Biomx |
| 12:30 - 12:45 | Nadav Kidron, CEO and Chairman of the Board, Oravax Medical |
| 12:45 - 13:00 | Einat Galamidi Cohen, MD, VP Medical, Enlivex Therapeutics |
| 13:00 - 13:15 | Ofer Chen, MD, VP Clinical Development, Clew Medical |
| 13:15 - 13:30 | Yotam Levin, MD, CEO, NanoPass |
| 13:30 - 13:45 | Eddie Sadan, Co-founder, Terrapeutics |
| 13:45 - 14:00 | Tamar Ben-Yedida, PhD, CSO, BiondVax Pharmaceuticals |
| 14:00 - 15:00 | Lunch Break |
| PLENARY SESSION | |
| 15:15 - 15:45 | Alban de la Sabliere, SVP, Head of Sanofi Partnering Sanofi, France, "Sanofi: Implementing a Play to a Win Strategy" |
| 15:45 - 16:15 | Ehud Rivlin, PhD, Israel Site Lead Verily, Israel |
| 16:15 - 16:45 | Tal Zaks, MD, PhD, Venture Partner, Orbimed, USA, "ZOOM" |
